Mayne Pharma poised to enter world’s largest pharmaceutical market
Finfeed Archived Apr 16, 2020
Mayne Pharma Group Limited (ASX: MYX) has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA), seeking marketing authorisation for E4/DRSP, a combined oral contraceptive indicated for the prevention of pregnancy.
Antisense appoints experienced biotech executive
Finfeed Archived Feb 28, 2020
Antisense Therapeutics Limited (ASX:ANP) has appointed Gil Price M.D. as Consultant Medical Director. Dr. Price is a clinical physician trained in internal medicine with a long-standing focus in drug development, adverse drug reactions, drug utilization and regulation.